Current Opinion in Obstetrics and Gynecology was launched in 1989. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of obstetrics and gynecology is divided into nine sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Editor and the Section Editor for this issue.
Jonathan S. Berek, MD, MMSc
Professor and Chair, College of Applied Anatomy, Executive Vice Chair, Department of Obstetrics & Gynecology, Chief, Division of Gynecologic Oncology and Gynecology Service, Director, UCLA Women's Reproductive Cancer Program, David Geffen School of Medicine at UCLA.
Dr. Berek is a Professor at UCLA and is the Chair of the College of Applied Anatomy at the David Geffen School of Medicine at UCLA. He also serves as the Executive Vice Chair of the Department of Obstetrics and Gynecology, as well as the Chief of the Division of Gynecologic Oncology and Gynecology Service, and the Director of the UCLA Women's Reproductive Cancer Program.
He is well known as a Pelvic Surgeon, Gynecologist and Gynecologic Oncologist. He is highly regarded for his research on the clinical management of gynecologic cancers and basic research related to these malignancies. He has published over 400 research papers, book chapters and monographs. He is especially noted for his books, Practical Gynecologic Oncology and Novak's Gynecology.
Dr. Berek earned his undergraduate degree from Brown, his doctor of medicine degree at Johns Hopkins University School of Medicine, completed his residency at Harvard Medical School, the Brigham and Women's Hospital, and his fellowship in gynecologic oncology at the UCLA School of Medicine.
His primary research interest is in the immunology and immunotherapy of ovarian cancer, and the development of experimental models and clinical trials. His research team's initial work with the use of intraperitoneal biologic response modifiers, especially interferons and interleukins, encouraged development of cytokine-mediated gene therapy strategies. In addition, through collaborative work, his team is focusing on the development of monoclonal antibodies and novel strategies for the treatment of ovarian cancer.
He is board certified by the American Board of Obstetrics and Gynecology, and the Division of Gynecologic Oncology. Dr. Berek has served as an examiner for the American Board Obstetrics & Gynecology and for the Council on Resident Education in Obstetrics and Gynecology (CREOG).
Dr. Berek's many honors include receiving the President's Award from the Society of Gynecologic Oncologists, serving as its Vice President in 1996–1997, and presenting numerous distinguished lectureships. He also is regularly listed among America's Best Doctors for Gynecology & Gynecologic Oncology. He was recently awarded the prestigious Excellence in Education Award by the David Geffen School of Medicine at UCLA.
He is an Editor of Prolog and Precis for the American College of Obstetrics and Gynecology. He is the Editor in Chief of Current Problems in Obstetrics and Gynecology, a Senior Editor of the International Journal of Gynecologic Cancer and has served on the editorial boards of the Journal of Clinical Oncology, Gynecologic Oncology, and the Journal of the Society for Gynecologic Investigation. He serves as a reviewer for Obstetrics & Gynecology, American Journal of Obstetrics and Gynecology, New England Journal of Medicine, Lancet, Cancer, and Journal of the National Cancer Institute, among others.
Dr. Berek has grant support from the National Cancer Institute. Dr. Berek has served on many national committees including the Clinical Cancer Programs Review Committees. He is also principal investigator for the Gynecologic Oncology Group.
Anne O. Rodriguez, MD
Dr. Rodriguez received her medical and undergraduate degrees with honors at Northwestern University in Chicago and completed her residency in Obstetrics and Gynecology at the University of North Carolina at Chapel Hill. She then completed a three year fellowship in Gynecologic Oncology at the University of Miami/ Jackson Memorial Hospital. She is currently Assistant Professor in the Department of Obstetrics and Gynecology at the University of California Davis Medical Center and also maintains an active clinical practice in gynecologic oncology. Her current research endeavors include population based outcomes research of cancer in pregnancy, and alternative therapies in malignancy. She currently serves on multiple local committees and at the national level in the Patient Education committee of the American College of Obstetricians and Gynecologists. She has a special interest in complementary medicine and is trained in medical acupuncture. She has also been active in volunteer work with the Physicians for Social Responsibility in Los Angeles.